- Home
- GRAL vs CION Comparison
GRAL vs CION Comparison
Compare GRAL & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAL
- CION
- Stock Information
- Founded
- GRAL 2016
- CION 2011
- Country
- GRAL United States
- CION United States
- Employees
- GRAL N/A
- CION N/A
- Industry
- GRAL
- CION Finance/Investors Services
- Sector
- GRAL
- CION Finance
- Exchange
- GRAL NYSE
- CION Nasdaq
- Market Cap
- GRAL 610.9M
- CION 593.9M
- IPO Year
- GRAL N/A
- CION N/A
- Fundamental
- Price
- GRAL $30.32
- CION $11.52
- Analyst Decision
- GRAL Hold
- CION Hold
- Analyst Count
- GRAL 2
- CION 2
- Target Price
- GRAL $16.00
- CION $12.25
- AVG Volume (30 Days)
- GRAL 1.1M
- CION 227.3K
- Earning Date
- GRAL 02-15-2025
- CION 03-13-2025
- Dividend Yield
- GRAL N/A
- CION 13.17%
- EPS Growth
- GRAL N/A
- CION 50.69
- EPS
- GRAL N/A
- CION 1.48
- Revenue
- GRAL $117,669,000.00
- CION $254,537,000.00
- Revenue This Year
- GRAL $32.48
- CION $1.10
- Revenue Next Year
- GRAL $14.72
- CION N/A
- P/E Ratio
- GRAL N/A
- CION $7.82
- Revenue Growth
- GRAL 111.83
- CION 3.26
- 52 Week Low
- GRAL $12.33
- CION $10.52
- 52 Week High
- GRAL $32.65
- CION $12.69
- Technical
- Relative Strength Index (RSI)
- GRAL N/A
- CION 54.34
- Support Level
- GRAL N/A
- CION $11.49
- Resistance Level
- GRAL N/A
- CION $11.76
- Average True Range (ATR)
- GRAL 0.00
- CION 0.16
- MACD
- GRAL 0.00
- CION 0.04
- Stochastic Oscillator
- GRAL 0.00
- CION 68.60
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies.